Simotinib hydrochloride

Modify Date: 2024-01-03 14:14:52

Simotinib hydrochloride Structure
Simotinib hydrochloride structure
Common Name Simotinib hydrochloride
CAS Number 1538617-88-7 Molecular Weight 537.41
Density N/A Boiling Point N/A
Molecular Formula C25H27Cl2FN4O4 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Simotinib hydrochloride


Simotinib hydrochloride is a selective, specific, and orally bioavailable EGFR tyrosine kinase inhibitor, with an IC50 of 19.9 nM. Antineoplastic activities[1].

 Names

Name Simotinib hydrochloride

 Simotinib hydrochloride Biological Activity

Description Simotinib hydrochloride is a selective, specific, and orally bioavailable EGFR tyrosine kinase inhibitor, with an IC50 of 19.9 nM. Antineoplastic activities[1].
Related Catalog
Target

EGFR:19.9 nM (pIC50)

In Vitro Simotinib hydrochloride inhibits in a dose-dependent manner EGFR and the growth of human A431 tumor cells with high expression of EGFR, with no significant activity on other investigated kinases[1].
In Vivo Simotinib hydrochloride has been shown to exert its antitumor activity by inhibiting EGFR phosphorylation in nude xenograft model[1].
References

[1]. Hu XS, et al. Safety, tolerability, and pharmacokinetics of simotinib, a novel specific EGFR tyrosine kinase inhibitor, in patients with advanced non-small cell lung cancer: results of a phase Ib trial. Cancer Manag Res. 2019;11:4449-4459. Published 2019 May 13.

 Chemical & Physical Properties

Molecular Formula C25H27Cl2FN4O4
Molecular Weight 537.41